Clin2
NCT06261333Likely a fitEnrolling by invitation

Quality of life study for HHT patients

Hereditary Hemorrhagic Telangiectasia

Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.

This study looks at how hereditary hemorrhagic telangiectasia (HHT) affects your day-to-day life and well-being. By joining, you'll answer questions to help doctors better understand the impact of the condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
250 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with HHT using standard criteria or a genetic test.
  • You can understand and speak German.
  • You are able to give your informed consent to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04469517Recruiting
Study of low-oxygen factors in hereditary bleeding disorder

This study looks at how “low-oxygen” signals may affect people with hereditary hemorrhagic telangiectasia (HHT), a genetic bleeding disorder. It may help researchers understand what drives symptoms and could guide future treatments.

Essen, North Rhine-Westphalia
NCT07826845Recruiting
Body donation for people with HHT

This study asks people with HHT (a genetic condition that causes abnormal blood vessels) to consider donating their body after death to help medical research. It aims to learn more about HHT by studying donated tissues.

Essen, North Rhine-Westphalia
NCT07101575Not yet recruiting
Heart health check for people with HHT

This study evaluates the heart health of people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels. By participating, you help doctors understand how HHT affects the heart, which may improve future care.

NCT06259292Recruiting
HHT patient registry tracking long-term outcomes

This registry collects health information from people with HHT over time to better understand the disease and improve care. Joining does not involve any experimental treatment, but your data will help researchers learn more about HHT.

Birmingham, Alabama
NCT07623525Recruiting· Phase 1/Phase 2
DIAG723 study for hereditary hemorrhagic telangiectasia

This study tests a new drug called DIAG723 in adults with hereditary hemorrhagic telangiectasia (HHT), a genetic condition that causes abnormal blood vessels and bleeding. Depending on which part of the study you qualify for, the drug may help reduce nosebleeds, improve anemia, or help with lung blood vessel problems caused by HHT.

Camperdown, New South Wales
NCT07474428Not yet recruiting
Quality of life in young people with HHT

This study is about understanding how HHT (a condition that causes abnormal blood vessels) affects quality of life in children and young adults. If you join, you (or your caregiver) will fill out a survey about your daily life and symptoms.

Cincinnati, Ohio

Hear when a new Hereditary Hemorrhagic Telangiectasia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.